Close

Unusual 11 Midday Movers 01/03: (AONE) (TAS) (QRM) Higher; (AVEO) (TSTC) (NEPT) Lower

January 3, 2012 2:51 PM EST
A123 (Nasdaq: AONE) 19.3% HIGHER; bouncing following a 10 percent decline over Thursday and Friday of last week. The price is back over the 200-day SMA today.

AVEO Pharmaceuticals, Inc. (Nasdaq: AVEO) 18.6% LOWER; and Astellas Pharma Inc. have announced that tivozanib demonstrated superiority over sorafenib in the primary endpoint of progression-free survival (PFS) in TIVO-1, a global, randomized Phase 3 clinical trial evaluating the efficacy and safety of investigational drug tivozanib compared to sorafenib in 517 patients with advanced renal cell carcinoma.

Tasman Metals (AMEX: TAS) 16.9% HIGHER; see Quest Rare Minerals.

Telestone Technologies Corporation (Nasdaq: TSTC) 16.1% LOWER; cuts its FY11 sales growth guidance from 30 percent to 15-20 percent, sees net income in the range of $16.8-$22.4 million, down from prior guidance of about $27.5 million.

Quest Rare Minerals (AMEX: QRM) 14.9% HIGHER; rare earth group moving higher, potentially on the heels of a secured agreement for Phase I production at Molycorp's (NYSE: MCP) Mountain Pass project. Molycorp shares are up 4.8 percent at last check; Rare Element (AMEX: REE) and Avalon Rare Metals (AMEX: AVL) shares are up 9.2 percent each.

USEC (NYSE: USU) 13.2% HIGHER; bounced over the 200-day SMA this morning and continues to trade higher.

Neptune Technologies & Bioressources (Nasdaq: NEPT) 12.1% LOWER; shares opened at $2.86 on the day after closing at $2.92 on December 30th. Shareholders look to be taking profits today.

MAKO Surgical (Nasdaq: MAKO) 12% HIGHER; upgraded from Neutral to Buy at Summer Street. Goldman also named the stock a top buy idea in the US medical technology sector this morning.

Universal Display (NASDAQ: PANL) 10.3% LOWER; Canaccord Genuity maintains a 'Hold' on Universal Display price target lowered from $40 to $35. Canaccord analyst, Jonathan Dorsheimer, said, "After triangulating the disclosure in UDC’s filings as well as follow-ups from some recent management commentary, we now believe that the implied rate the Samsung license is based off of is lower than we originally expected. We believe that the rate is closer to 75bps, resulting in a $290-300M licensing opportunity through 2017, down from our earlier assumption of 100bps and a $350-375M licensing opportunity."

Gafisa SA (NYSE: GFA) 10.8% HIGHER; the stock traded higher in Brazil yesterday amid speculation for a decline in rates and a better-than-expected inflation outlook for 2012.

Groupon (Nasdaq: GRPN) 6.6% LOWER; according to Reuters, a survey conducted by Yipit and Susquehanna Financial Group shows that 8 out of 10 merchants enjoyed doing business with Groupon (as well as others daily deal sites like LivingSocial). Click here to see the full report.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Special Reports

Related Entities

Susquehanna International Group of Companies